REGN Financial Facts

Interest expense: -11.68M
Investment income: 456K
See Full Income Statement

Commitments and contingencies: 0
Other assets: 20.08M
See Full Balance Sheet

Earnings History for Regeneron Pharmaceuticals, Inc. (REGN)

  |   Expand Research on REGN
Next EPS Date 7/24/13 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +102.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.7%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/3/13 Q113 $1.78$1.46 +$0.32$440M$424.26M N/A / N/A N/A +7.4% Details
2/14/13 Q412 $1.47$1.11 +$0.36$415M$392.64M N/A / N/A N/A +56.7% Details
10/24/12 Q312 $1.89$0.96 +$0.93$428M$349.17M N/A / N/A N/A +74.5% Details
7/25/12 Q212 $0.90$0.25 +$0.65$304M$255.98M N/A / N/A N/A +119.8% Details
11/30/99 Q112 $0.00-$0.24 +$0.24N/A$172.62M N/A / N/A N/A +110% Details
2/13/12 Q411 -$0.37-$0.60 +$0.23$123M$131.04M N/A / N/A N/A +161.5% Details
7/28/11 Q211 -$0.69-$0.41 -$0.28$107.8M$121.51M N/A / N/A N/A +407.1% Details
5/3/11 Q111 -$0.49-$0.36 -$0.13$112.2M$117.02M N/A / N/A N/A +397.1% Details
Like REGN Earnings? Also take a look at SNY, AGN, MRVL, DM

REGN Earnings News